Acquiring Company
BDR Pharmaceuticals
Acquired Company
Acme Formulation Private Limited
MumbaiIndiaBiotechnologyHealth CareManufacturingDescription
BDR Pharma has agreed with PAG to acquire a controlling stake in the oral solid formulations business of Acme Formulation Private Limited and its subsidiaries. The deal strengthens BDR Pharma's CDMO platform and adds capabilities in thyroid therapies and female sex hormones. PAG and Viral Shah will retain full ownership of Immacule, Acme's sterile injectable business.
Quick answer
BDR Pharmaceuticals is acquiring Acme Formulation Private Limited, announced November 13, 2026. BDR Pharmaceuticals is based in Mumbai, Maharashtra, India.
- How much did BDR Pharmaceuticals pay for Acme Formulation Private Limited?
- The deal value was not disclosed.
- What does BDR Pharmaceuticals do?
- BDR Pharmaceuticals is a healthcare company focused on the development and production of quality medicines.
- Where are BDR Pharmaceuticals and Acme Formulation Private Limited based?
- BDR Pharmaceuticals is based in Mumbai, Maharashtra, India. Acme Formulation Private Limited is based in India.
- Who are the decision-makers at BDR Pharmaceuticals?
- Fundz holds 1 contact at BDR Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Biotechnology and Health Care
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Western Microsurgical acquires Q Surgical and Proficient Surgical (October 27, 2026)
- PAI Pharma acquires Nexus Pharmaceuticals (November 12, 2026)
- Nelipak acquires Technipaq for healthcare packaging (November 11, 2026)
- BioAdaptives, Inc. to acquire Xycota Biosciences LLC to Expand Biotechnology Portfolio (November 4, 2026)
- Globus Medical acquires Synaptive Medical (November 3, 2026)
- AddLife acquires Portuguese distributor MoonSurge (November 2, 2026)
Who to call at BDR Pharmaceuticals, and when
When BDR Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day BDR Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BDR Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BDR Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BDR Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Acme Formulation Private Limited?
Acme Formulation Private Limited was acquired by BDR Pharmaceuticals, based in Mumbai. The deal was reported on November 13, 2026. BDR Pharmaceuticals is a healthcare company focused on the development and production of quality medicines. BDR Pharmaceuticals is privately held and operates in Biotechnology.
When did BDR Pharmaceuticals acquire Acme Formulation Private Limited?
BDR Pharmaceuticals's acquisition of Acme Formulation Private Limited was reported on November 13, 2026. BDR Pharma has agreed with PAG to acquire a controlling stake in the oral solid formulations business of Acme Formulation Private Limited and its subsidiaries. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Acme Formulation Private Limited do?
Acme Formulation Private Limited is an Indian contract manufacturer whose oral solid formulations business is being sold. Its subsidiaries are included in the transaction. Its founder is Viral Shah. It is privately held, operating in Manufacturing, and is based in India.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.